EZH2, a HMT at H3K27 site and the subunit of polycomb repressor complex 2 (PRC2), is widely acknowledged to be overexpressed in multiple types of cancer,74 mainly showing high expression in NE prostate cancer.20 This evidence concerns the gene EZH2 and prostate cancer.